Ming-Yow Hung | Medicine and Dentistry | Research Excellence Award

Published on by NESIN Awards

Prof. Ming-Yow Hung | Medicine and Dentistry | Research Excellence Award

Professor | Shuang Ho Hospital, Taipei Medical University | Taiwan

Dr. Ming Yow Hung is a distinguished researcher at Taipei Medical University, Taiwan, specializing in cardiovascular biology, molecular cardiology, and stem cell research. His work focuses on understanding coronary artery disorders, including vasospasm, Kounis syndrome, and allergic myocardial infarction, through experimental, translational, and epigenetic approaches. He has authored numerous peer-reviewed publications, with significant citation impact reflecting his influence in cardiovascular and pharmaceutical research. Dr. Hung collaborates extensively with international teams, contributing to multidisciplinary studies that integrate molecular mechanisms, induced pluripotent stem cell models, and clinical insights. His research advances understanding of disease mechanisms and informs therapeutic strategies, with clear societal relevance in improving cardiovascular health, personalized medicine, and patient care, positioning him as a globally recognized and impactful scientist in cardiovascular research.

Citation Metrics (Scopus)

1,824
1,400
900
450
0

Citations

1,824

Documents

57

h-index

20

Citations

Documents

h-index

View Scopus Profile
 View ORCID Profile

Featured Publications

Xin Li | Sports Medicine | Best Researcher Award

Published on by NESIN Awards

Assoc. Prof. Dr. Xin Li | Sports Medicine | Best Researcher Award

Associate Professor| Tianjin Normal University | China

Dr. Xin Li is an accomplished scholar and educator specializing in clinical medicine and sports health sciences, currently serving as an Associate Professor at Tianjin Normal University since 2006. She obtained her Doctor of Medicine (MD) in Clinical Medicine from Tianjin Medical University in July 2006. Over nearly two decades of academic and research experience, Dr. Li has established herself as a leading expert at the intersection of clinical medicine, exercise science, and health management. Her teaching portfolio encompasses a range of courses in sports health, exercise rehabilitation, and health management, with a focus on integrating clinical case studies into theoretical instruction to enhance students’ practical competencies and professional insight. Dr. Li’s research primarily addresses exercise interventions for chronic diseases, sports injury prevention, and rehabilitation science, contributing to the growing evidence base linking physical activity with disease prevention and functional recovery. She has led and participated in numerous provincial and municipal research projects, achieving notable outcomes that have advanced the application of medical principles in sports health practice. To date, Dr. Li has published over ten academic papers in peer-reviewed core journals and international conferences, several of which have been widely cited and recognized within the academic community for their methodological rigor and clinical relevance. Her collaborative approach bridges disciplines such as physiology, public health, and kinesiology, fostering innovation and interdisciplinary integration in sports medicine research. Beyond academia, Dr. Li’s work holds significant societal impact, promoting the scientific development of exercise-based health strategies for chronic disease management and population well-being. Combining solid clinical expertise, pedagogical excellence, and a strong research record, Dr. Xin Li continues to contribute meaningfully to the advancement of sports health education and evidence-based medical practice in China and beyond.

Profile: Scopus 

Featured Publications

Li, X. (2025). The influence of initial and final character positional probabilities on the flexibility of position coding in two-character word identification. Acta Psychologica Sinica.

Dr. Xin Li’s work bridges clinical medicine and sports science, advancing evidence-based approaches to exercise intervention, chronic disease prevention, and rehabilitation. Her research and teaching contribute to improving public health outcomes and enhancing human performance, promoting global innovation in integrated medical and sports health education.

Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Published on by NESIN Awards

Prof. Dr. Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Directors of Department in Hospital| Tongji University | China

Dr. Shaoqing Yu, PhD, is the Director of the Departments of Otorhinolaryngology–Head and Neck Surgery and Allergy at Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. An accomplished clinician-scientist, Dr. Yu specializes in allergy, immunology, and otorhinolaryngology, with a research focus on the mechanisms and clinical management of allergic rhinitis and upper airway inflammation. He has led or participated in more than 20 major research projects, including those funded by the National Natural Science Foundation of China, and has published over 70 peer-reviewed papers in high-impact international journals such as JAMA, Allergy, Clinical and Experimental Allergy, and Clinical Reviews in Allergy & Immunology. His work has substantially advanced understanding of immune regulation and translational therapies in allergic diseases. Dr. Yu is an active member of the European Academy of Allergy and Clinical Immunology (EAACI) and the Chinese Society of Otolaryngology in Traditional Chinese and Western Medicine, fostering global and interdisciplinary collaborations. His achievements have been recognized through numerous awards, including the Third Prize of the Shanghai Medical Technology Award, the Third Prize of the Military Medical Achievement Award, and the Tongji University Taihe Medical Education Award. With over 20 patents to his name and selection for the prestigious Shanghai Oriental Talent Plan, Dr. Yu continues to contribute significantly to medical innovation, education, and the improvement of public health outcomes in China and internationally.

Profiles: Scopus | ORCID 

Featured Publications

Yu, S., et al. (2025). An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: The DUBHE randomized clinical trial. Nature Communications.

Yu, S., et al. (2025). Efficacy and safety of intranasal corticosteroids combined with mucoactive drugs for chronic rhinosinusitis. International Immunopharmacology.

Yu, S., et al. (2025). Xylulose 5-phosphate fosters sustained antitumor activity of progenitor-like exhausted SLC35E2⁺ CD8⁺ T effector cells. Cell Metabolism.

Yu, S., et al. (2025). Automatic segmentation of clear cell renal cell carcinoma based on deep learning and a preliminary exploration of the tumor microenvironment. Translational Andrology and Urology.

Yu, S., et al. (2025). Long-term administration of hydrogen-rich water enhances quality of life in diabetic rats and reduces renal neoplasm incidence through modulation of inflammatory and metabolic pathways. Translational Andrology and Urology.

Dr. Shaoqing Yu’s pioneering research in allergy and immunology has advanced understanding of airway inflammatory diseases and driven the development of innovative diagnostic and therapeutic strategies. His work bridges basic science and clinical application, improving patient outcomes and shaping global standards in allergic disease management.

Gwendolyn Quinn | Medicine and Dentistry | Best Researcher Award

Published on by NESIN Awards

Prof. Dr. Gwendolyn Quinn | Medicine and Dentistry | Best Researcher Award

Professor| New York University| United States

Dr. Gwendolyn P. Quinn is an internationally recognized behavioral scientist and bioethicist whose research focuses on patient–provider communication, reproductive ethics, and quality of life among cancer patients, particularly adolescents, young adults, and sexual and gender minority populations. She is Professor and Vice Chair of Research in the Departments of Obstetrics and Gynecology and Population Health at the New York University Grossman School of Medicine, where she also holds the Livia Wan Endowed Chair and is a member of the Division of Medical Ethics and the Perlmutter Cancer Center. Dr. Quinn’s work integrates behavioral science, ethics, and public health to enhance communication about reproductive health, genetics, and fertility preservation for individuals undergoing gonadotoxic treatment. She directs the NCI-funded ENRICH/ECHO training program, which improves oncology providers’ communication skills in reproductive and genetic health, and has contributed to national and international guidelines for ASCO, ASRM, and the PANCARE Life consortium. With more than 450 peer-reviewed publications—approximately 300 focused on reproductive health and bioethics—Dr. Quinn has significantly influenced research and practice in oncofertility, ethics, and cancer survivorship. She has served on the Board of Scientific Counselors for the National Institute of Environmental Health Sciences and holds fellowships in the American Association for Cancer Education and the New York Academy of Medicine. Her numerous honors, including the American Psychosocial Oncology Society’s Outstanding Education and Training Award, reflect her sustained leadership and impact on advancing equitable reproductive health care, ethical medical practice, and the education of future generations of researchers and clinicians worldwide.

Profiles: Google Scholar |Scopus | ORCID

Featured Publications

Loren, A. W., Mangu, P. B., Beck, L. N., Brennan, L., Magdalinski, A. J., Partridge, A. H., … & Quinn, G. P. (2013). Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology, 31(19), 2500–2510. Cited by: 1,901

Oktay, K., Harvey, B. E., Partridge, A. H., Quinn, G. P., Reinecke, J., Taylor, H. S., … & Loren, A. W. (2018). Fertility preservation in patients with cancer: ASCO clinical practice guideline update. Journal of Clinical Oncology, 36(19), 1994–2001. Cited by: 1,663

Quinn, G. P., Sanchez, J. A., Sutton, S. K., Vadaparampil, S. T., Nguyen, G. T., Green, B. L., … & Schabath, M. B. (2015). Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA: A Cancer Journal for Clinicians, 65(5), 384–400. Cited by: 551

Quinn, G. P., Vadaparampil, S. T., Lee, J. H., Jacobsen, P. B., Bepler, G., Lancaster, J., & Keefe, D. L. (2009). Physician referral for fertility preservation in oncology patients: A national study of practice behaviors. Journal of Clinical Oncology, 27(35), 5952–5957. Cited by: 490

Nahata, L., Tishelman, A. C., Caltabellotta, N. M., & Quinn, G. P. (2017). Low fertility preservation utilization among transgender youth. Journal of Adolescent Health, 61(1), 40–44. Cited by: 345

 

Dr. Gwendolyn P. Quinn’s pioneering work in reproductive ethics, patient–provider communication, and oncofertility has transformed clinical practice and education worldwide, advancing equitable reproductive health care for cancer patients and sexual and gender minorities. Her research and training initiatives have shaped global guidelines and strengthened ethical, compassionate communication in medicine.

Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Published on by NESIN Awards

Dr. Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Specialist | University of health sciences | Turkey

Dr. Nermin Mutlu Bilgic is a Gastroenterology Specialist at the University of Health Sciences Ümraniye Training and Research Hospital in Istanbul, Türkiye. She earned her Doctor of Medicine degree from Istanbul University Cerrahpaşa Faculty of Medicine in 2004, completed her residency in Internal Medicine at Maltepe University between 2007 and 2012, and obtained her subspecialty in Gastroenterology at Ümraniye Training and Research Hospital from 2015 to 2019. With over fifteen years of academic and clinical experience, Dr. Bilgiç specializes in hepatology, metabolic liver diseases, and inflammatory gastrointestinal disorders. She has served as Principal Investigator for international multicenter clinical trials evaluating the efficacy and safety of Saroglitazar Magnesium in patients with Primary Biliary Cholangitis and Nonalcoholic Steatohepatitis, reflecting her active contribution to global research in liver diseases. She has received certified training in Good Clinical Practice (GCP) from Roche/Genentech and the Global Health Training Centre, ensuring compliance with international ethical and regulatory standards. Dr. Bilgiç has authored and co-authored peer-reviewed publications and presented her work at several national and international gastroenterology and internal medicine conferences. Her professional focus integrates patient-centered clinical care with translational research aimed at improving therapeutic outcomes and understanding the mechanisms of chronic liver disease. She is also actively engaged in mentoring residents and fellows, contributing to medical education and the advancement of clinical research culture within her institution. Through her leadership in clinical trials, scientific collaborations, and commitment to ethical medical practice, Dr. Nermin Mutlu Bilgiç continues to make a meaningful impact on the advancement of gastroenterology and hepatology in both national and international contexts.

Profiles: Google Scholar | ORCID

Featured Publications

Kul, S., Caliskan, Z., Guvenc, T. S., Celik, F. B., Sarmis, A., Atici, A., Konal, O., Akıl, M., & Bilgiç, N. M. (2023). Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with …. Microvascular Research, 146, 104458 Cited by 31

Sayar, S., Aykut, H., Kaya, Ö., Kürbüz, K., Ak, Ç., Gökçen, P., Bilgiç, N. M., Adalı, G., & others. (2021). Bone mineral density screening and the frequency of osteopenia/osteoporosis in Turkish adult patients with celiac disease. The Turkish Journal of Gastroenterology, 32(7), 600–606 Cited by 13

Sayar, S., Kürbüz, K., Kahraman, R., Öztürk, O., Çalışkan, Z., Doğanay, H. L., Bilgiç, N. M., & others. (2020). Risk of hepatitis B reactivation during anti-TNF therapy: Evaluation of patients with past hepatitis B infection. The Turkish Journal of Gastroenterology, 31(7), 522–528 Cited by 13

Ozdil, K., Ozturk, O., Çalık, E. S., Akbas, E. S., Kanat, E., Caliskan, Z., Demirdag, H., Bilgiç, N. M., & others. (2016). Relationship between size of varices and platelet count/spleen size ratio in cirrhotic patients. Northern Clinics of Istanbul, 3(1), 46–50 Cited by 11

Adali, G., Bilgiç, N. M., Kalaman, A. E., Ozturk, O., & Ozdil, K. (2023). Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study. Hepatology Forum, 4(3), 129–135 Cited by 8

 

Dr. Nermin Mutlu Bilgic work advances the understanding and management of chronic liver and metabolic diseases through evidence-based clinical research and international collaboration. Her contributions to hepatology and gastroenterology foster improved patient outcomes, support ethical research practices, and drive innovation in global liver health.

Luigi Montano | Medicine and Dentistry | Outstanding Scientist Award

Published on by NESIN Awards

Dr. Luigi Montano | Medicine and Dentistry | Outstanding Scientist Award

Medico at Local Health Authority Salerno, Italy

Dr. Luigi Montano, MD, PhD, is a distinguished Italian physician-scientist with extensive expertise in urology, andrology, and environmental reproductive health. With over three decades of clinical experience, he currently serves as Head of the Public Andrology Clinic and Lifestyle Medicine Service in UroAndrology at ASL Salerno. He holds a PhD in Evolutionary Biology and Ecology and is a national authority in reproductive health research. Dr. Montano is the founder and coordinator of the EcoFoodFertility project, which explores the impact of environmental and dietary factors on male fertility, alongside leading several multidisciplinary research initiatives on microplastics, rare earth elements, and environmental exposures. He has delivered presentations at numerous national and international conferences and has played a key role in organizing scientific congresses, particularly through his leadership in the Italian Society of Human Reproduction (SIRU). His work highlights a unique integration of clinical practice and environmental medicine, making him a strong candidate for the Outstanding Scientist Award.

Professional Profile 

Education🎓

Dr. Luigi Montano has a strong and diverse educational background that underpins his expertise in medicine, urology, and environmental health. He earned his Medical Degree (MD) with honors, followed by a specialization in Urology, equipping him with in-depth clinical and surgical skills in male reproductive health. Driven by a passion for scientific research and ecological well-being, he pursued a PhD in Evolutionary Biology and Ecology, which broadened his understanding of environmental influences on human health, particularly reproductive function. His academic journey reflects a multidisciplinary approach, blending classical medical training with advanced ecological and biological sciences. Throughout his education, Dr. Montano consistently demonstrated academic excellence and a commitment to integrating scientific research with clinical practice. His educational achievements laid the foundation for his pioneering role in projects like EcoFoodFertility and his leadership in public health initiatives, reinforcing his reputation as a thought leader in both urology and environmental medicine.

Professional Experience📝

Dr. Luigi Montano has amassed extensive professional experience at the intersection of clinical medicine, research, and environmental health. As a urologist and andrologist with the Italian National Health Service, he has provided expert care in male reproductive health for decades. Beyond his clinical role, Dr. Montano is the National Coordinator of the EcoFoodFertility project, a groundbreaking multidisciplinary study investigating the impact of environmental pollutants on human fertility. His leadership has united researchers from over 50 institutions across Europe, emphasizing a holistic approach to reproductive and environmental well-being. He has also served as a consultant for various governmental and health organizations, contributing to public health strategies on environmental sustainability and reproductive risks. Dr. Montano’s expertise is frequently sought in national and international conferences, and he plays a key role in advocacy efforts related to ecological health. His professional journey exemplifies a blend of patient care, scientific inquiry, and policy influence.

Research Interest🔎

Dr. Luigi Montano’s research interests lie at the crossroads of reproductive health, environmental medicine, and public health. He is particularly focused on exploring how environmental pollutants—such as endocrine disruptors, heavy metals, and air and water contaminants—affect male fertility and overall human health. As the founder and coordinator of the EcoFoodFertility project, Dr. Montano investigates semen quality as a biomarker of environmental exposure, using it as an early warning system for ecological and public health risks. His work integrates epidemiological, clinical, and molecular approaches to assess the effects of environmental stressors on human reproductive systems. He is also interested in the role of nutrition and lifestyle as mediators of environmental impact, emphasizing preventive strategies to mitigate health risks. Through his multidisciplinary collaborations, Dr. Montano aims to influence public health policy and promote ecological responsibility, ultimately advancing a new paradigm that links environmental quality with human reproductive well-being.

Award and Honor🏆

Dr. Luigi Montano has received numerous awards and honors in recognition of his groundbreaking contributions to environmental medicine and reproductive health. His pioneering work on the EcoFoodFertility project, which explores semen quality as a biomarker of environmental exposure, has earned him national and international acclaim. He has been invited as a keynote speaker at prestigious scientific conferences and has received accolades for promoting innovative, interdisciplinary approaches to public health. Among his notable honors is his appointment as President of the Italian Society of Environmental Medicine (SIMA), reflecting his leadership in the field. Dr. Montano has also been recognized by various scientific institutions and public health organizations for his efforts to link environmental sustainability with human well-being. His contributions have not only advanced scientific knowledge but have also influenced health policy and environmental awareness, positioning him as a leading voice in promoting ecological responsibility for the benefit of future generations.

Research Skill🔬

Dr. Luigi Montano possesses a diverse and advanced set of research skills that bridge the fields of environmental medicine, epidemiology, and reproductive health. He is highly proficient in designing and conducting epidemiological studies that investigate the impact of environmental pollutants on human fertility. His expertise includes biomonitoring, statistical analysis, and the integration of clinical and environmental data to establish meaningful correlations. Dr. Montano is skilled in interdisciplinary collaboration, coordinating efforts across medical, scientific, and ecological domains, which is evident in his leadership of the EcoFoodFertility project. He excels in translating complex scientific findings into practical public health strategies and policy recommendations. Furthermore, he is experienced in publishing peer-reviewed research, leading scientific committees, and engaging in international research networks. His ability to synthesize data from various sources and disciplines underpins his innovative approaches to studying the interactions between environmental factors and human health, making his research skills both comprehensive and impactful.

Conclusion💡

Dr. Luigi Montano is highly suitable for the Outstanding Scientist Award due to his exceptional leadership in reproductive health research, interdisciplinary and translational science focus, and commitment to sustainable medicine. His initiatives like EcoFoodFertility demonstrate innovation and global relevance. To further strengthen his candidacy, clarifying measurable research outputs (publications, impact factor, funding) would be beneficial.

Publications Top Noted✍️

  1. Pironti C, Ricciardi M, Motta O, Miele Y, Proto A, Montano L.
    Microplastics in the environment: intake through the food web, human exposure and toxicological effects

    • Journal: Toxics

    • Year: 2021

    • Citations: 274

  2. Pironti C, Ricciardi M, Proto A, Bianco PM, Montano L, Motta O.
    Endocrine-disrupting compounds: An overview on their occurrence in the aquatic environment and human exposure

    • Journal: Water

    • Year: 2021

    • Citations: 218

  3. Montano L, Pironti C, Pinto G, Ricciardi M, Buono A, Brogna C, Venier M, et al.
    Polychlorinated biphenyls (PCBs) in the environment: occupational and exposure events, effects on human health and fertility

    • Journal: Toxics

    • Year: 2022

    • Citations: 193

  4. Pironti C, Notarstefano V, Ricciardi M, Motta O, Giorgini E, Montano L.
    First evidence of microplastics in human urine, a preliminary study of intake in the human body

    • Journal: Toxics

    • Year: 2022

    • Citations: 173

  5. Montano L, Giorgini E, Notarstefano V, Notari T, Ricciardi M, Piscopo M, et al.
    Raman Microspectroscopy evidence of microplastics in human semen

    • Journal: Science of the Total Environment

    • Year: 2023

    • Citations: 120

  6. Ricciardi M, Pironti C, Motta O, Miele Y, Proto A, Montano L.
    Microplastics in the aquatic environment: occurrence, persistence, analysis, and human exposure

    • Journal: Water

    • Year: 2021

    • Citations: 99

  7. Vecoli C, Montano L, Andreassi MG.
    Environmental pollutants: genetic damage and epigenetic changes in male germ cells

    • Journal: Environmental Science and Pollution Research

    • Year: 2016

    • Citations: 85

  8. Lettieri G, D’Agostino G, Mele E, Cardito C, Esposito R, Cimmino A, Montano L, et al.
    Discovery of the involvement in DNA oxidative damage of human sperm nuclear basic proteins of healthy young men living in polluted areas

    • Journal: International Journal of Molecular Sciences

    • Year: 2020

    • Citations: 80

  9. Bergamo P, Volpe MG, Lorenzetti S, Mantovani A, Notari T, Cocca E, Montano L, et al.
    Human semen as an early, sensitive biomarker of highly polluted living environment in healthy men

    • Journal: Reproductive Toxicology

    • Year: 2016

    • Citations: 77

  10. Bosco L, Notari T, Ruvolo G, Roccheri MC, Martino C, Chiappetta R, Montano L, et al.
    Sperm DNA fragmentation: An early and reliable marker of air pollution

  • Journal: Environmental Toxicology and Pharmacology

  • Year: 2018

  • Citations: 67

  1. Lettieri G, Marra F, Moriello C, Prisco M, Notari T, Trifuoggi M, Giarra A, Montano L, et al.
    Molecular alterations in spermatozoa of a family case living in the land of fires—a first look at possible transgenerational effects of pollutants

  • Journal: International Journal of Molecular Sciences

  • Year: 2020

  • Citations: 65

  1. Montano L, Ceretti E, Donato F, Bergamo P, Zani C, Viola GCV, Notari T, et al.
    Effects of a lifestyle change intervention on semen quality in healthy young men living in highly polluted areas in Italy: the FASt randomized controlled trial

  • Journal: European Urology Focus

  • Year: 2022

  • Citations: 64

Shadi Hamoud | Heart diseases | Best Researcher Award

Published on by NESIN Awards

Dr. Shadi Hamoud | Heart diseases | Best Researcher Award

Head, research unit at Rambam Health Care Campus, Israel

Dr. Shadi Hamoud is a distinguished physician, researcher, and academic leader specializing in internal medicine, atherosclerosis, and novel cardiovascular treatments. With an MD (cum laude) from Hebrew University and an MPA from the University of Haifa, he serves as a Clinical Senior Lecturer at the Technion-Israel Institute of Technology and Deputy Director of Internal Medicine E at Rambam Medical Center. His research focuses on lipoproteins oxidation, heparanase enzyme roles in kidney and liver diseases, and international clinical trials on cardiovascular medicine, diabetes, and COVID-19 therapies. He has mentored numerous graduate students, contributed extensively to clinical research, and secured competitive research grants. His leadership extends to ethics committees, pharmaceutical consulting, and medical education. Recognized with multiple teaching excellence awards, he actively contributes to professional societies, public health initiatives, and medical advancements, making him a strong candidate for the Best Researcher Award. However, a broader international research collaboration could further enhance his impact.

Professional Profile

Education🎓

Dr. Shadi Hamoud holds an MD degree with cum laude honors from the Hebrew University of Jerusalem, demonstrating his strong academic foundation in medicine. He further pursued an Executive Master of Public Administration (MPA) at the University of Haifa, equipping him with leadership and administrative skills essential for medical research and healthcare management. Throughout his education, he developed a keen interest in internal medicine, atherosclerosis, and cardiovascular diseases, which later became the core of his research. His academic journey also includes specialized training in clinical research, medical ethics, and translational medicine, enhancing his expertise in both theoretical and practical aspects of healthcare. His commitment to continuous learning is evident in his involvement with international research projects and advanced training programs. His diverse educational background not only strengthens his medical proficiency but also enables him to contribute significantly to healthcare policy, medical education, and clinical advancements in cardiovascular and metabolic diseases.

Professional Experience 📝

Dr. Shadi Hamoud is a distinguished physician and researcher specializing in internal medicine, atherosclerosis, and cardiovascular diseases. He has extensive professional experience in clinical practice, medical research, and healthcare administration. As a senior physician, he has worked in leading hospitals, diagnosing and treating complex cardiovascular and metabolic disorders. His expertise extends to translational medicine, bridging the gap between research and patient care. Dr. Hamoud has also been actively involved in clinical trials, contributing to groundbreaking studies on lipid metabolism and atherosclerosis. His leadership roles in medical institutions and research committees reflect his dedication to advancing medical knowledge and improving patient outcomes. Additionally, he has collaborated with international experts, publishing numerous high-impact research papers in peer-reviewed journals. His commitment to medical education is evident through mentoring young researchers and medical students, ensuring the next generation of healthcare professionals is well-equipped to tackle emerging challenges in cardiovascular and metabolic diseases.

Research Interest🔎

Dr. Shadi Hamoud’s research interests focus on cardiovascular diseases, atherosclerosis, and lipid metabolism, with a particular emphasis on the mechanisms underlying cardiovascular risk factors. His work explores the role of cholesterol, inflammation, and metabolic disorders in the development of atherosclerosis, aiming to identify novel therapeutic targets for prevention and treatment. He is also deeply interested in translational medicine, bridging laboratory research with clinical applications to enhance patient care. Dr. Hamoud has contributed significantly to studies on lipid-lowering therapies, biomarkers for cardiovascular risk assessment, and the impact of lifestyle modifications on heart health. His research extends to the intersection of metabolic disorders such as diabetes and obesity with cardiovascular disease, seeking innovative strategies to reduce morbidity and mortality. Through collaborations with international research institutions, he continues to advance scientific understanding in cardiovascular medicine, striving to develop more effective diagnostic tools and personalized treatment approaches for patients with cardiovascular and metabolic diseases.

Award and Honor🏆

Dr. Shadi Hamoud has received numerous awards and honors in recognition of his outstanding contributions to cardiovascular research and medicine. His excellence in scientific innovation and dedication to improving cardiovascular health have earned him prestigious accolades from medical and research institutions worldwide. He has been honored with awards for his groundbreaking work in lipid metabolism and atherosclerosis, highlighting his impact on the field. Additionally, Dr. Hamoud has received research grants and fellowships that have supported his pioneering studies in cardiovascular disease prevention and treatment. His contributions have been recognized through invitations to speak at international conferences, where he has shared his expertise with the global medical community. He has also been acknowledged for his mentorship and leadership in guiding young researchers in the field. Through his achievements, Dr. Hamoud continues to make significant advancements in cardiovascular medicine, earning widespread recognition for his dedication to scientific excellence and patient care.

Research Skill🔬

Dr. Shadi Hamoud possesses exceptional research skills that have significantly advanced the field of cardiovascular medicine. His expertise spans a wide range of methodologies, including molecular biology techniques, lipid metabolism analysis, and advanced imaging technologies for cardiovascular assessment. He is proficient in designing and conducting clinical and laboratory-based studies, utilizing statistical tools to analyze complex datasets, and translating research findings into clinical applications. Dr. Hamoud excels in grant writing and securing research funding, demonstrating his ability to lead high-impact projects. His strong problem-solving skills and critical thinking enable him to address challenging scientific questions effectively. Additionally, his collaborative approach fosters interdisciplinary research, enhancing innovation in cardiovascular disease prevention and treatment. With a keen eye for detail and a commitment to scientific integrity, Dr. Hamoud consistently produces high-quality research that contributes to medical advancements, making him a highly respected figure in the scientific and medical communities.

Conclusion💡

Dr. Shadi Hamoud is a highly suitable candidate for the Best Researcher Award, given his exceptional contributions to cardiovascular research, clinical medicine, and medical education. His extensive mentorship, leadership in international clinical trials, and commitment to translational medicine make him a strong contender. Strengthening his global visibility and publishing more in top-tier journals could further enhance his profile.

Publications Top Noted✍️

  • Title: Potential Nephroprotective Effect of uPA against Ischemia/Reperfusion-Induced Acute Kidney Injury in αMUPA Mice and HEK-293 Cells
    Authors: H.A. Alkhaleq, Heba Abd; I. Hacker, Israel; T. Karram, Tony; A. Kabala, Aviva; Z.A. Abassi, Zaid A.
    Year: 2024

  • Title: Involvement of Heparanase in the Pathogenesis of Acute Pancreatitis: Implication of Novel Therapeutic Approaches
    Authors: D.B. Hamo-Giladi, Dalit B.; A. Fokra, Ahmad; E. Sabo, Edmond; Z.A. Abassi, Zaid A.; I. Khamaysi, Iyad
    Year: 2024

  • Title: Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury
    Authors: H.A. Alkhaleq, Heba Abd; S. Hamoud, Shadi; I. Hacker, Israel; A. Kabala, Aviva; Z.A. Abassi, Zaid A.
    Year: 2024
    Citations: 2

 

Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Published on by NESIN Awards

Mr. Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Medical Student at California Northstate University College of Medicine, United States

Andrew J. Goulian is a dedicated medical student at California Northstate University College of Medicine (Class of 2026) and a recipient of the U.S. Navy Health Professions Scholarship Program (HPSP). With an MPH from Columbia University and a BA in Neuroscience, he has demonstrated strong academic excellence, leadership, and research expertise. His work spans addiction medicine, military medicine, and orthopaedic trauma, with multiple peer-reviewed publications and conference presentations. Goulian has led clinical trials, collaborated with pharmaceutical sponsors, and contributed to public health initiatives, including harm reduction research in Native American communities. His leadership roles include serving as an AMA Medical Student Section representative and president of multiple student organizations. With extensive experience in clinical research, teaching, and mentorship, he has made significant contributions to medical innovation and public health. His diverse expertise and commitment to advancing healthcare make him a strong candidate for the Future-Focused Innovation Pioneer Award.

Professional Profile 

Education

Andrew J. Goulian has a strong educational background in medicine, public health, and neuroscience. He is currently pursuing his Doctor of Medicine (MD) degree at California Northstate University College of Medicine (Class of 2026) and is a recipient of the prestigious U.S. Navy Health Professions Scholarship Program (HPSP). Prior to medical school, he earned a Master of Public Health (MPH) degree from Columbia University, where he focused on health policy, epidemiology, and harm reduction strategies. His undergraduate studies were completed at the University of Southern California (USC), where he obtained a Bachelor of Arts in Neuroscience, equipping him with a strong foundation in biomedical sciences and research methodology. Throughout his academic career, Goulian has been actively engaged in clinical research, leadership roles, and community outreach, demonstrating a commitment to advancing healthcare through both scientific inquiry and service. His diverse educational background uniquely positions him for success in medical innovation.

Professional Experience

Andrew J. Goulian has a diverse professional background spanning clinical research, public health, and military service. As a U.S. Navy Health Professions Scholarship Program (HPSP) recipient, he is committed to serving as a future military physician. His experience includes working as a clinical research coordinator, where he contributed to studies in neurology and public health, focusing on harm reduction strategies and epidemiological research. He has also been involved in healthcare policy initiatives, leveraging his Master of Public Health (MPH) training from Columbia University to analyze and develop strategies for improving medical access and patient outcomes. Additionally, Goulian has held leadership roles in medical student organizations, demonstrating a passion for mentorship and community outreach. His combined expertise in medicine, public health, and research underscores his commitment to advancing healthcare both in civilian and military settings. His professional journey reflects a strong dedication to service, innovation, and evidence-based medicine.

Research Interest

Andrew J. Goulian’s research interests lie at the intersection of medicine, public health, and military healthcare. He is particularly focused on neurology, harm reduction strategies, and epidemiological research aimed at improving patient outcomes. His work in clinical research has explored neurological disorders and their broader implications for public health, emphasizing data-driven approaches to treatment and intervention. Additionally, he has been involved in studies on healthcare policy and access, seeking to identify systemic barriers and develop solutions to enhance medical care delivery. His Master of Public Health (MPH) training has further reinforced his interest in preventive medicine and population health, particularly in optimizing healthcare strategies for both civilian and military populations. With a strong commitment to evidence-based medicine, Goulian is dedicated to research that advances medical innovation, improves patient care, and supports healthcare initiatives that benefit diverse communities, including those in military and underserved settings.

Award and Honor

​As of now, there is no publicly available information regarding awards and honors received by Mr. Andrew Goulian. His professional profile highlights his role as a second-year medical student at California Northstate University and his active involvement in clinical research at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute. During his internship, he collaborated with Dr. Meir Marmor on studies utilizing advanced ultrasound technologies to assess Acute Compartment Syndrome. Additionally, as an officer in the U.S. Navy, his dedication to trauma research is influenced by its significant impact on military personnel. While his commitment to research and the military community is evident, specific awards or honors have not been documented in the available sources.

Research Skill

Mr. Andrew Goulian possesses strong research skills, particularly in the field of orthopaedic trauma and medical technology. As a clinical research intern at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute, he has gained experience in conducting studies involving advanced ultrasound technologies to assess Acute Compartment Syndrome. His work requires proficiency in data collection, analysis, and interpretation, as well as a thorough understanding of clinical research methodologies. Additionally, his role involves collaboration with medical professionals and researchers, demonstrating his ability to work effectively in a team-oriented research environment. His background as a second-year medical student at California Northstate University further enhances his ability to integrate medical knowledge with research applications. Moreover, his position as an officer in the U.S. Navy suggests strong leadership and problem-solving abilities, which are crucial in conducting impactful research. His dedication to trauma research highlights his analytical mindset and commitment to advancing medical science.

Conclusion

Andrew J. Goulian is a strong candidate for the Future-Focused Innovation Pioneer Award, given his cutting-edge research, leadership in medical innovation, and contributions to digital health solutions. If he continues to translate his research into real-world healthcare solutions, policy influence, or industry-changing innovations, he would be an even more compelling choice.

Publications Top Noted

  • Authors: Y. Abgin, K.K. Umemoto, A. Goulian, O.G. Ahmed, D.M. Tang
  • Year: 2024
  • Title: Accuracy and Completeness of Bard and Chat-GPT 4 Responses for Questions Derived from the International Consensus Statement on Endoscopic Skull-Base Surgery 2019
  • Journal: Journal of Neurological Surgery, Part B: Skull Base
  • Publication Type: Research Article

Calver Pang | Medicine and Dentistry | Best Researcher Award

Published on by NESIN Awards

Dr. Calver Pang | Medicine and Dentistry | Best Researcher Award

Plastic Surgery Registrar at UCL, Division of Surgery & Interventional Science, United Kingdom

Dr. Calver Pang is an accomplished medical researcher and plastic surgery specialist with extensive experience in vascular malformations. He holds a PhD from University College London and has completed a prestigious surgical research fellowship at Johns Hopkins University. With multiple peer-reviewed publications and contributions to systematic reviews, his work has significantly influenced clinical practice, particularly in sclerotherapy and molecular pathogenesis. He has secured over £146,000 in research grants, including funding from The Butterfly AVM Charity and The Royal Free Charity. Recognized with several research awards, including the Qualitative Research Winner (Society of Academic & Research Society, 2020), he has demonstrated a strong commitment to advancing medical science. His multidisciplinary collaborations, spanning vascular and plastic surgery, pharmacology, and nanotechnology, highlight his innovative approach. While further leadership in large-scale trials could strengthen his profile, his impressive research achievements and clinical impact make him a strong contender for the Best Researcher Award.

Professional Profile 

Education

Dr. Calver Pang has a distinguished educational background spanning medicine, surgery, and pharmacology. He earned his MBChB from the University of Leicester in 2015, followed by Membership of the Royal College of Surgeons (MRCS) Edinburgh in 2021. He is currently pursuing a PhD at University College London (UCL), focusing on biomarkers in vascular malformations, demonstrating his commitment to advancing medical research. Additionally, he holds a First-Class Honours MPharm degree from UCL’s School of Pharmacy (2010), showcasing his strong foundation in both medicine and pharmacology. His dedication to medical education is further evident through his Associate Fellowship of the Higher Education Academy (AFHEA, 2021). Beyond formal education, he has completed multiple advanced surgical training courses, including ATLS, CCrISP, and EMSB, enhancing his expertise in trauma, critical care, and reconstructive surgery. His diverse academic qualifications highlight his interdisciplinary expertise, making him a well-rounded and accomplished researcher and clinician.

Professional Experience

Dr. Calver Pang has an extensive and diverse professional background in surgery and medical research. Currently, he is a Specialty Training (ST4) plastic surgery trainee at Cambridge University Hospitals (2024–2025), following his ST3 role in the same department. His expertise spans plastic, vascular, trauma, orthopaedic, and general surgery, having trained at prestigious institutions such as the Royal Free London NHS Foundation Trust, University Hospitals of Leicester, and Addenbrooke’s Hospital. His international experience includes a Surgical Research Fellowship at Johns Hopkins University (2015–2017), where he contributed to cutting-edge research in surgery. Additionally, he served as a Clinical Research Fellow at the Royal Free London NHS Trust (2017–2020), focusing on vascular malformations and gene therapy. His career reflects a strong balance between clinical excellence and research innovation, with leadership in multi-disciplinary studies and numerous high-impact publications. His expertise in both clinical practice and academia makes him a standout in his field.

Research Interest

Mr. Calver Pang’s research interests lie at the intersection of vascular malformations, plastic surgery, and regenerative medicine. His PhD at University College London focuses on the characterization of biomarkers in vascular malformations, aiming to improve diagnostic accuracy and treatment strategies. He has extensively studied embolotherapy, sclerotherapy, and molecular pathogenesis, contributing to advancements in minimally invasive interventions. His work also extends to gene therapy and nanotechnology in wound healing, demonstrating his innovative approach to translational medicine. He has published multiple peer-reviewed articles on mental health and quality of life in patients with congenital vascular disorders, emphasizing holistic patient care. Additionally, his interest in botulinum toxin therapy for vascular conditions showcases his commitment to pioneering new treatments. With a strong foundation in both clinical and laboratory-based research, he continues to explore novel therapies that bridge the gap between basic science and real-world medical applications, ultimately improving patient outcomes.

Award and Honor
Mr. Calver Pang has received numerous awards and honors in recognition of his outstanding contributions to medical research and surgery. He was awarded the Qualitative Research Winner by the Society of Academic & Research Society (2020) and the ASiT Virtual Event Bursary (2020), highlighting his excellence in academic research. He has secured multiple prestigious grants, including The Butterfly AVM Charity Grant (£136,080, 2019) and The Royal Free Charity Grant (£10,000, 2019), supporting his work in vascular malformations. His achievements also include the Robert Brown Travel Award from UCL (2019) and various elective scholarships, such as the British Medical and GlaxoSmithKline Dental Students’ Trust (£800, 2015) and the British Association of Plastic Reconstructive and Aesthetic Surgeons bursary (£500, 2015). His recognition at both national and international levels reflects his dedication to advancing medical science, making him a highly regarded researcher and clinician in his field.

Research Skill

Mr. Calver Pang possesses a diverse and advanced set of research skills, making him a distinguished medical researcher. He is highly proficient in clinical and translational research, with expertise in biomarker analysis, histopathology, and molecular pathogenesis of vascular malformations. His ability to design and conduct systematic reviews, multicenter studies, and observational research has led to numerous high-impact publications. He is skilled in statistical analysis, data interpretation, and research methodology, ensuring rigorous and evidence-based conclusions. His experience in grant writing and securing competitive funding—amounting to over £146,000 in research grants—demonstrates his ability to drive independent research projects. Additionally, he has experience in nanotechnology and gene therapy, applying innovative approaches to wound healing and regenerative medicine. His multidisciplinary collaborations across vascular surgery, plastic surgery, and pharmacology further enhance his research versatility. His analytical mindset and dedication to advancing medical knowledge make him a leading researcher in his field.

Conclusion

Mr. Calver Pang is a highly suitable candidate for the Best Researcher Award, with a strong research background, multiple grants, and impactful publications. His contributions to vascular malformation research and multidisciplinary approach set him apart. While he could further solidify his leadership with larger-scale studies and more high-impact journal publications, his current achievements make him a compelling contender for the award.

Publications Top Noted

  • Author(s): Pang, C., Iakovou, D., Fraser, D., Langridge, B.J., Butler, P.E.M.
  • Year: 2025
  • Title: A systematic review of botulinum toxin as a treatment for Raynaud’s disease secondary to scleroderma
  • Journal: Clinical Rheumatology

Peter Lorenz | Pharmaceutical Science | Best Researcher Award

Published on by NESIN Awards

Dr. Peter Lorenz | Pharmaceutical Science | Best Researcher Award

Wissenschaftlicher Mitarbeiter at WALA Heilmittel GmbH, Phytochemische Forschung, Germany

Dr. Peter Lorenz is an accomplished research chemist with over two decades of experience in phytochemical and natural product research. His work spans multiple domains, including analytical plant chemistry, marine chemistry, neurobiology, and industrial plant extraction. Throughout his career, he has contributed to advancing scientific knowledge in natural products, particularly their isolation and potential applications in medicine and industry. His international research experience, leadership roles, and interdisciplinary expertise make him a distinguished figure in the field. Currently, he serves as a senior researcher at WALA Heilmittel GmbH, focusing on analytical plant chemistry and the isolation of bioactive compounds.

Professional Profile 

Education

Dr. Lorenz earned his Ph.D. in Chemistry from Martin-Luther-University Halle-Wittenberg in 1995. Before that, he completed his undergraduate studies in Chemistry at the Technical University of Merseburg from 1986 to 1990. His academic background provided a strong foundation for his subsequent research, particularly in the areas of phytochemistry, marine chemistry, and neurobiology.

Professional Experience

Dr. Lorenz has held various research positions in academia and industry. He worked as a postdoctoral researcher at Colorado State University and the Scripps Institution of Oceanography, specializing in plant and marine chemistry. He later contributed to neurobiological research at Otto-von-Guericke University, focusing on the effects of natural products on neurodegenerative diseases. In the industrial sector, he developed plant extraction procedures at Kaden Biochemicals and led laboratory operations at Chemisches Laboratorium Dr. K. Richter. Since 2007, he has been a senior researcher at WALA Heilmittel GmbH, where he specializes in analytical plant chemistry and the isolation of bioactive compounds.

Research Interest

Dr. Peter Lorenz’s research focuses on phytochemistry, natural product isolation, and analytical plant chemistry. His work explores the extraction and characterization of bioactive compounds from plants and marine sources, with applications in medicine, pharmaceuticals, and industrial processes. He has also contributed to neurobiological research, studying the effects of natural products on neurodegenerative diseases. His interdisciplinary approach integrates chemistry, biology, and pharmacology to advance the understanding of natural compounds and their therapeutic potential.

Awards and Honors

While specific awards and honors are not listed in his profile, Dr. Lorenz’s extensive career and leadership roles in research institutions suggest recognition within the scientific community. His contributions to natural product chemistry and analytical research have likely earned him professional credibility and respect. Additional details on awards, fellowships, or honorary positions would further highlight his achievements in the field.

Research Skills

Dr. Lorenz possesses expertise in analytical chemistry, chromatography, spectroscopy, and advanced natural product isolation techniques. His proficiency extends to plant and marine chemistry, industrial extraction processes, and bioactive compound characterization. He has experience in leading laboratory teams, designing experiments, and applying his knowledge to pharmaceutical and neurobiological research. His diverse skill set enables him to contribute to both academic and industrial advancements in chemical and biological sciences.

Conclusion

Dr. Peter Lorenz is a strong candidate for the Best Researcher Award due to his extensive experience in analytical and natural product chemistry, leadership roles, and international research exposure. However, highlighting high-impact publications, previous awards, and research funding would further strengthen his nomination.

Publications Top Noted

  • It Is Not All about Alkaloids—Overlooked Secondary Constituents in Roots and Rhizomes of Gelsemium sempervirens (L.) J.St.-Hil
    Authors: Lilo K. Mailänder, Khadijeh Nosrati Gazafroudi, Peter Lorenz, Rolf Daniels, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2024
    DOI: 10.3390/plants13162208

  • Impact of Fermentation on the Phytochemical Profile and Bioactivity Characteristics of Aqueous Matricaria recutita L. Root Extracts
    Authors: Lilo K. Mailänder, Khadijeh Nosrati Gazafroudi, Marit Greiß, Peter Lorenz, Sven Nicolay, Carsten Gründemann, Florian C. Stintzing, Rolf Daniels, Dietmar R. Kammerer
    Year: 2024
    DOI: 10.1002/cbdv.202400159

  • Comparison of Aqueous and Lactobacterial-Fermented Mercurialis perennis L. (Dog’s Mercury) Extracts with Respect to Their Immunostimulating Activity
    Authors: Peter Lorenz, Ilona Zilkowski, Lilo K. Mailänder, Iris Klaiber, Sven Nicolay, Manuel Garcia-Käufer, Amy M. Zimmermann-Klemd, Claudia Turek, Florian C. Stintzing, Dietmar R. Kammerer et al.
    Year: 2023
    DOI: 10.3390/fermentation9020190

  • Phytochemical Characterization of Chamomile (Matricaria recutita L.) Roots and Evaluation of Their Antioxidant and Antibacterial Potential
    Authors: Lilo K. Mailänder, Peter Lorenz, Hannes Bitterling, Florian C. Stintzing, Rolf Daniels, Dietmar R. Kammerer
    Year: 2022
    DOI: 10.3390/molecules27238508

  • Insight into the Secondary Metabolites of Geum urbanum L. and Geum rivale L. Seeds (Rosaceae)
    Authors: Marek Bunse, Peter Lorenz, Florian Stintzing, Dietmar Kammerer
    Year: 2021
    DOI: 10.3390/plants10061219

  • Impact of Environmental Conditions on Growth and the Phenolic Profile of Achillea atrata L.
    Authors: Lysanne Salomon, Peter Lorenz, Bernhard Ehrmann, Otmar Spring, Florian C. Stintzing, Dietmar Kammerer
    Year: 2021
    DOI: 10.3390/pr9050853

  • Comparison of the Phenolic Compound Profile and Antioxidant Potential of Achillea atrata L. and Achillea millefolium L.
    Authors: Lysanne Salomon, Peter Lorenz, Marek Bunse, Otmar Spring, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2021
    DOI: 10.3390/molecules26061530

  • Comprehensive Phytochemical Characterization of Herbal Parts from Kidney Vetch (Anthyllis vulneraria L.) by LC/MSⁿ and GC/MS
    Authors: Peter Lorenz, Marek Bunse, Iris Klaiber, Jürgen Conrad, Tino Laumann-Lipp, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2020
    DOI: 10.1002/cbdv.202000485

  • Front Cover: Comprehensive Phytochemical Characterization of Herbal Parts from Kidney Vetch (Anthyllis vulneraria L.) by LC/MSⁿ and GC/MS
    Authors: Peter Lorenz, Marek Bunse, Iris Klaiber, Jürgen Conrad, Tino Laumann-Lipp, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2020
    DOI: 10.1002/cbdv.202000788